4.4 Article

Acceleration and inhibition of amyloid-β fibril formation by peptide-conjugated fluorescent-maghemite nanoparticles

期刊

JOURNAL OF NANOPARTICLE RESEARCH
卷 13, 期 8, 页码 3521-3534

出版社

SPRINGER
DOI: 10.1007/s11051-011-0276-4

关键词

Fluorescent gamma-Fe2O3 nanoparticle; Neurodegenerative disease; Amyloid-beta peptide; Protein folding; Aggregation kinetics; Nanomedicine

资金

  1. BSF (Israel-USA Binational Science Foundation)
  2. Minerva Grant (Microscale and Nanoscale Particles and Films)

向作者/读者索取更多资源

The formation of amyloid aggregates by association of peptides into ordered structures is hallmark of certain neurodegenerative disorders. Exploring the effect of specific nanoparticles on the formation of amyloid fibrils may contribute toward a mechanistic understanding of the aggregation processes, leading to design nanoparticles that modulate the formation of toxic amyloid plaques. Uniform maghemite (gamma-Fe2O3) magnetic nanoparticles, containing fluorescein covalently encapsulated within (F-gamma-Fe2O3)(,) were prepared. These F-gamma-Fe2O3 nanoparticles of 14.0 +/- A 4.0 nm were then coated with human serum albumin (HSA) via a precipitation process. Covalent conjugation of the spacer arm succinimidyl polyethylene glycol succinimidyl ester (NHS-PEG-NHS) to the F-gamma-Fe(2)O(3 similar to)HSA nanoparticles was then accomplished by interacting the primary amine groups of the HSA coating with excess NHS-PEG-NHS molecules. Covalent conjugation of the peptides amyloid-beta 40 (A beta(40)) or Leu-Pro-Phe-Phe-Asp (LPFFD) onto the surface of the former fluorescent nanoparticles was then performed, by interacting the terminal activated NHS groups of the PEG derivatized F-gamma-Fe(2)O(3 similar to)HSA nanoparticles with primary amino groups of the peptides. Kinetics of the A beta(40) fibrillation process in the absence and presence of varying concentrations of the A beta(40) or LPFFD conjugated nanoparticles were also elucidated. The non-peptide conjugated fluorescent nanoparticles do not affect the A beta(40) fibrillation process significantly. However, the A beta(40)-conjugated nanoparticles (F-gamma-Fe2O3 similar to HSA-PEG-A beta(40)) accelerate the fibrillation process while the LPFFD-conjugated nanoparticles (F-gamma-Fe(2)O(3 similar to)HSA-PEG-LPFFD) inhibit it. By applying MRI and fluorescence imaging techniques simultaneously these bioactive fluorescent magnetic iron oxide nanoparticles can be used as an efficient tool to study and control the A beta(40) amyloid fibril formation process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据